Pandey Anshuman, Mishra Ashish Kumar
Department of Surgical Gastroenterology, Chattrapati Shahuji Maharaj University, Lucknow, India.
BMJ Case Rep. 2011 May 3;2011:bcr0720103181. doi: 10.1136/bcr.07.2010.3181.
Pseudomyxoma peritonei (PMP) is a rare disease and even after advances in its understanding and management it often has a protracted course and multiple recurrences despite aggressive surgery and intraperitoneal chemotherapy. The current preferred treatment of ultraradical surgery and hyperthermic intraperitoneal chemotherapy is associated with considerable morbidity and significant mortality. With better understanding we know that the prognosis of the disease is dependent on the degree of total excision of the disease and type of histology. The authors propose the need to be selective in applying aggressive treatment regimens in all patients with PMP regardless of factors like age, low malignant variants and expected morbidities. Our patient had a good outcome with a conservative approach. However, large studies are needed before reaching a conclusion.
腹膜假黏液瘤（PMP）是一种罕见疾病，即便在对其认识和治疗方面取得了进展，尽管采取了积极的手术和腹腔内化疗，它通常病程迁延且多次复发。目前首选的超根治性手术和热灌注腹腔内化疗治疗方法伴有相当高的发病率和显著的死亡率。随着认识的加深，我们知道该疾病的预后取决于疾病的完全切除程度和组织学类型。作者提出，对于所有PMP患者，无论年龄、低恶性变体和预期发病率等因素如何，在应用积极的治疗方案时都需要有所选择。我们的患者采用保守方法取得了良好疗效。然而，在得出结论之前还需要进行大量研究。
